![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, March 11, 2021 8:25:36 AM
Will take time to make money but proof of product is there.
The valuation is fair at this point - upside maybe 50-70% by end of the year based on how they price and are able show sale.
The payment cycle with insurance will be key as the product is very high priced -
Recent RYTM News
- Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency • GlobeNewswire Inc. • 06/28/2024 12:00:14 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/17/2024 09:28:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 09:19:14 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 06/11/2024 08:01:00 PM
- Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024 • GlobeNewswire Inc. • 06/03/2024 08:02:00 PM
- Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference • GlobeNewswire Inc. • 06/03/2024 12:02:00 PM
- Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome • GlobeNewswire Inc. • 05/22/2024 08:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:21:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/09/2024 08:17:00 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 05/09/2024 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:43:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:10:20 AM
- Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology • GlobeNewswire Inc. • 04/29/2024 10:30:00 PM
- Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 • GlobeNewswire Inc. • 04/24/2024 08:01:00 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 04/16/2024 08:01:00 PM
- Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 03/11/2024 08:01:00 PM
- Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences • GlobeNewswire Inc. • 03/06/2024 09:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/29/2024 09:58:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:46:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 09:44:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 09:05:53 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM